Aurinia Pharmaceuticals (AUPH) Work In Process (2023 - 2025)
Historic Work In Process for Aurinia Pharmaceuticals (AUPH) over the last 3 years, with Q3 2025 value amounting to $42.6 million.
- Aurinia Pharmaceuticals' Work In Process changed N/A to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year change of. This contributed to the annual value of $36.6 million for FY2024, which is 201.47% down from last year.
- Latest data reveals that Aurinia Pharmaceuticals reported Work In Process of $42.6 million as of Q3 2025.
- In the past 5 years, Aurinia Pharmaceuticals' Work In Process ranged from a high of $43.2 million in Q2 2025 and a low of $36.6 million during Q4 2024
- Over the past 3 years, Aurinia Pharmaceuticals' median Work In Process value was $41.7 million (recorded in 2025), while the average stood at $40.3 million.
- Within the past 5 years, the most significant YoY rise in Aurinia Pharmaceuticals' Work In Process was 201.47% (2024), while the steepest drop was 201.47% (2024).
- Aurinia Pharmaceuticals' Work In Process (Quarter) stood at $37.4 million in 2023, then decreased by 2.01% to $36.6 million in 2024, then rose by 16.42% to $42.6 million in 2025.
- Its Work In Process stands at $42.6 million for Q3 2025, versus $43.2 million for Q2 2025 and $41.7 million for Q1 2025.